BRPI0909209A2 - Composto indolinona - Google Patents
Composto indolinonaInfo
- Publication number
- BRPI0909209A2 BRPI0909209A2 BRPI0909209-9A BRPI0909209A BRPI0909209A2 BR PI0909209 A2 BRPI0909209 A2 BR PI0909209A2 BR PI0909209 A BRPI0909209 A BR PI0909209A BR PI0909209 A2 BRPI0909209 A2 BR PI0909209A2
- Authority
- BR
- Brazil
- Prior art keywords
- indolinone compound
- indolinone
- compound
- Prior art date
Links
- -1 Indolinone Compound Chemical class 0.000 title 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
- C07D209/02—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
- C07D209/04—Indoles; Hydrogenated indoles
- C07D209/30—Indoles; Hydrogenated indoles with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to carbon atoms of the hetero ring
- C07D209/32—Oxygen atoms
- C07D209/34—Oxygen atoms in position 2
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/10—Laxatives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/12—Antidiarrhoeals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/14—Prodigestives, e.g. acids, enzymes, appetite stimulants, antidyspeptics, tonics, antiflatulents
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
- C07D209/02—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
- C07D209/04—Indoles; Hydrogenated indoles
- C07D209/30—Indoles; Hydrogenated indoles with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to carbon atoms of the hetero ring
- C07D209/32—Oxygen atoms
- C07D209/38—Oxygen atoms in positions 2 and 3, e.g. isatin
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/06—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
- C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
- C07D403/06—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
- C07D405/06—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
- C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
- C07D417/06—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
Landscapes
- Organic Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Pharmacology & Pharmacy (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Nutrition Science (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Indole Compounds (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2008095040 | 2008-04-01 | ||
| PCT/JP2009/056431 WO2009123080A1 (ja) | 2008-04-01 | 2009-03-30 | インドリノン化合物 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| BRPI0909209A2 true BRPI0909209A2 (pt) | 2015-08-25 |
Family
ID=41135456
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| BRPI0909209-9A BRPI0909209A2 (pt) | 2008-04-01 | 2009-03-31 | Composto indolinona |
Country Status (13)
| Country | Link |
|---|---|
| US (1) | US20110009379A1 (pt) |
| EP (1) | EP2261206A4 (pt) |
| JP (1) | JPWO2009123080A1 (pt) |
| KR (1) | KR20100135248A (pt) |
| CN (1) | CN101983188A (pt) |
| AU (1) | AU2009232836A1 (pt) |
| BR (1) | BRPI0909209A2 (pt) |
| CA (1) | CA2720275A1 (pt) |
| IL (1) | IL208164A0 (pt) |
| MX (1) | MX2010010871A (pt) |
| RU (1) | RU2010144548A (pt) |
| WO (1) | WO2009123080A1 (pt) |
| ZA (1) | ZA201006623B (pt) |
Families Citing this family (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20130203715A1 (en) | 2010-07-20 | 2013-08-08 | Pulmatrix, Inc. | Use of trp channel agonists to treat infections |
| WO2012078519A2 (en) * | 2010-12-06 | 2012-06-14 | Numerate, Inc. | 3-acylidene-2-oxoindole derivatives for inhibition of transglutaminase 2 |
| US9182233B2 (en) * | 2012-05-17 | 2015-11-10 | Robert Bosch Gmbh | System and method for autocompletion and alignment of user gestures |
| US10482265B2 (en) * | 2015-12-30 | 2019-11-19 | International Business Machines Corporation | Data-centric monitoring of compliance of distributed applications |
| KR102620902B1 (ko) * | 2020-04-24 | 2024-01-04 | 가천대학교 산학협력단 | 신규 알파-시누클레인 방사성 리간드 및 이를 포함하는 신경퇴행성 질환 진단용 조성물 |
| CN113545316B (zh) * | 2020-04-24 | 2022-05-17 | 中国科学院上海药物研究所 | 血根碱在制备trpa1通道激动剂中的应用 |
| EP4434358A4 (en) | 2021-11-16 | 2025-10-22 | House Foods Group Inc | COMPOSITION FOR INCREASING THE QUANTITY OF FOOD INGESTED AND/OR IMPROVING ANOREXIA, AND COMPOSITION FOR ACTIVATING AN ANKYRIN 1 WITH TRANSIENT RECEPTOR POTENTIAL |
| JPWO2024096014A1 (pt) | 2022-10-31 | 2024-05-10 |
Family Cites Families (14)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB1239553A (pt) * | 1967-08-16 | 1971-07-21 | ||
| US3428649A (en) | 1968-01-23 | 1969-02-18 | Mcneilab Inc | Oxindole derivatives |
| BR9910095A (pt) * | 1998-05-01 | 2000-12-26 | Lilly Co Eli | Compostos inibidores de spla2 para tratamento de doença |
| TWI270545B (en) * | 2000-05-24 | 2007-01-11 | Sugen Inc | Mannich base prodrugs of 3-(pyrrol-2-ylmethylidene)-2-indolinone derivatives |
| US7244721B2 (en) | 2000-07-21 | 2007-07-17 | Schering Corporation | Peptides as NS3-serine protease inhibitors of hepatitis C virus |
| CA2508290C (en) | 2002-12-20 | 2017-02-28 | Ciba Specialty Chemicals Holding Inc. | Synthesis of amines and intermediates for the synthesis thereof |
| WO2006105796A1 (en) * | 2005-04-08 | 2006-10-12 | Leo Pharma A/S | Novel indolinone derivatives |
| US8101580B2 (en) * | 2005-04-21 | 2012-01-24 | Astellas Pharma Inc. | Therapeutic agent for irritable bowel syndrome |
| JP2007047770A (ja) * | 2005-07-13 | 2007-02-22 | Fujifilm Corp | 感光性組成物 |
| ATE541239T1 (de) * | 2005-07-13 | 2012-01-15 | Fujifilm Corp | Lichtempfindliche zusammensetzung |
| US8883841B2 (en) * | 2005-11-23 | 2014-11-11 | The Board Of Regents Of The University Of Texas System | Oncogenic ras-specific cytotoxic compound and methods of use thereof |
| EP2049520A4 (en) * | 2006-08-07 | 2011-01-05 | Ironwood Pharmaceuticals Inc | indole compounds |
| JP4591599B2 (ja) * | 2006-10-06 | 2010-12-01 | アステラス製薬株式会社 | 消化管運動改善剤スクリーニング法 |
| TW201242961A (en) * | 2007-06-20 | 2012-11-01 | Ironwood Pharmaceuticals Inc | FAAH inhibitors |
-
2009
- 2009-03-30 KR KR1020107021951A patent/KR20100135248A/ko not_active Withdrawn
- 2009-03-30 AU AU2009232836A patent/AU2009232836A1/en not_active Abandoned
- 2009-03-30 WO PCT/JP2009/056431 patent/WO2009123080A1/ja not_active Ceased
- 2009-03-30 RU RU2010144548/04A patent/RU2010144548A/ru not_active Application Discontinuation
- 2009-03-30 MX MX2010010871A patent/MX2010010871A/es not_active Application Discontinuation
- 2009-03-30 CN CN2009801125228A patent/CN101983188A/zh active Pending
- 2009-03-30 EP EP09729006A patent/EP2261206A4/en not_active Withdrawn
- 2009-03-30 US US12/922,936 patent/US20110009379A1/en not_active Abandoned
- 2009-03-30 JP JP2010505883A patent/JPWO2009123080A1/ja active Pending
- 2009-03-30 CA CA2720275A patent/CA2720275A1/en not_active Abandoned
- 2009-03-31 BR BRPI0909209-9A patent/BRPI0909209A2/pt not_active IP Right Cessation
-
2010
- 2010-09-15 ZA ZA2010/06623A patent/ZA201006623B/en unknown
- 2010-09-15 IL IL208164A patent/IL208164A0/en unknown
Also Published As
| Publication number | Publication date |
|---|---|
| ZA201006623B (en) | 2011-11-30 |
| KR20100135248A (ko) | 2010-12-24 |
| EP2261206A4 (en) | 2011-08-17 |
| CN101983188A (zh) | 2011-03-02 |
| IL208164A0 (en) | 2010-12-30 |
| US20110009379A1 (en) | 2011-01-13 |
| JPWO2009123080A1 (ja) | 2011-07-28 |
| AU2009232836A1 (en) | 2009-10-08 |
| WO2009123080A1 (ja) | 2009-10-08 |
| CA2720275A1 (en) | 2009-10-08 |
| RU2010144548A (ru) | 2012-05-10 |
| EP2261206A1 (en) | 2010-12-15 |
| MX2010010871A (es) | 2010-10-26 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| DK2288375T3 (da) | Pegylerede insulin-lispro-forbindelser | |
| BRPI0920707A2 (pt) | compostos | |
| DK2242759T3 (da) | Forbindelser | |
| DK2340021T3 (da) | Substituerede pyrrolidin-2-carboxamider | |
| DE602009000234D1 (de) | msignals | |
| BRPI0907376A2 (pt) | Fotobiorretador | |
| BRPI0914649A2 (pt) | Piprazolo-quinazolinas | |
| SMT201600045B (it) | Composti tetraciclinici c7-fluoro sostituiti | |
| DE602008003972D1 (de) | Sitzrücklehnungsmechanismus | |
| BRPI0914942A2 (pt) | Compostos de oxindol | |
| DE602008003521D1 (de) | Sitzrücklehnungsmechanismus | |
| BRPI0918602A2 (pt) | composto (i) | |
| DK2297162T3 (da) | Forbindelser | |
| DE602008003970D1 (de) | Strahlstromkalibriersystem | |
| BRPI0907522A2 (pt) | biarlamidas | |
| BRPI0916432A2 (pt) | compostos | |
| BRPI0915562A2 (pt) | tamis melhorado | |
| BRPI0922098A2 (pt) | composto inorgânicos | |
| BRPI0915442A2 (pt) | tamis melhorado | |
| DE112009000183A5 (de) | Sicherheitsvorreiber | |
| BRPI0923592A2 (pt) | composto | |
| BRPI0909634A2 (pt) | 2-aminoquinolinas | |
| BRPI0911393A2 (pt) | composto de 5-hidroxipirimidina-4-carboxamida | |
| DE112009001946A5 (de) | Mobelauszugsführung | |
| DE602009000488D1 (de) | Obstvereinzelvorrichtung |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| B08F | Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette] |
Free format text: REFERENTE AS 5A E 6A ANUIDADES. |
|
| B08K | Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette] |
Free format text: EM VIRTUDE DO ARQUIVAMENTO PUBLICADO NA RPI 2344 DE 08-12-2015 E CONSIDERANDO AUSENCIA DE MANIFESTACAO DENTRO DOS PRAZOS LEGAIS, INFORMO QUE CABE SER MANTIDO O ARQUIVAMENTO DO PEDIDO DE PATENTE, CONFORME O DISPOSTO NO ARTIGO 12, DA RESOLUCAO 113/2013. |